Nadina Grosios outlines the regulatory path from academic drug discovery to market, highlighting key studies and concepts that support clinical trial submissions, funding access, and partnership…
Philippe Tschopp explores how aligning manufacturing design with regulatory and clinical strategy enhances the development of oral solid drug products. He focuses on GMP, GLP, and TPP as key…
Thomas Hanke shares his perspective on how to strategically plan and execute preclinical validation for translational academic research. Drawing on his experience at Evotec—a leading biotechnology…
A new study from the European Patent Office explores how innovation ecosystems are shaping the future of oncology, with knowledge transfer playing a crucial role in bridging the gap between research and market-ready solutions. New Frontiers in Oncology: An Evolving Innovation Ecosystem provides a…
Learn about essential IP strategies for healthcare spin-outs, focusing on how tailored approaches for biotech, pharma, and digital health innovations can ensure long-term success. Join experts Sara…
Tanja Kova?i? presents The Impact Fund of the University of Ljubljana – The HUD Fund. She highlights the fund’s role in enhancing social sciences, arts, and humanities research impact and…
Join Katrina Bradley and BioMedical SIG for a webinar on market access strategies in life sciences. Learn to plan, execute, and optimise early tech deployment.
Mattia Ronchetti’s presentation focuses on EU and US regulatory frameworks for medical devices. It explores classification, clinical evaluation, and development plans, emphasising regulatory…
Matthias Versele, Executive Director of Drug Discovery at CD3-Cistim, discusses strategies for translational life sciences projects, from novel ideas to regulatory approval. He highlights how…
From September 2024 until May 2025 on the last Tuesday of the month, ASTP's BioMedical SIG invites you to participate in the new webinar series: 'From research and innovation to development: how to plan and execute translational projects in life sciences'.
Support the Biomedical Special Interest Group by contributing to their survey.
Joss Moorkens explores AI’s impact on translation. He addresses ethical challenges, such as bias and environmental impact, alongside AI literacy. Highlighting the balance between human oversight…
In 2020, Benjamin Soffer presents the KHP MedTech Accelerator. He outlines its role in fostering MedTech innovation, offering funding, mentorship, and access to infrastructure for start-ups. The…
In 2020, Laura Spinardi discusses managing and valorising clinical data. She addresses ethical considerations, GDPR compliance, data agreements, and the role of big data in clinical innovation.…
Mark Anderson (2012) examines the drafting and negotiation of CTAs. He addresses key issues like regulatory compliance, intellectual property rights, liability, and indemnities, providing practical guidance on balancing stakeholder interests, ensuring clarity, and managing risks in clinical trial…
Mark Anderson (2009) provides detailed guidance on drafting and negotiating CTAs. He covers regulatory compliance, intellectual property, liability, and indemnities, emphasising clear contractual terms to balance stakeholder interests and navigate legal complexities effectively.
Joris Swennen and Sander Van Loock (2013) analyse key challenges in forming consortia. They address IP ownership, co-ownership, background access, and publication, emphasising clear communication, legal certainty, and tailored agreements to balance academic and industry interests effectively.
This case study (2016) presents the TechID model, where dedicated units within hospitals identify and support innovations from clinical staff. The approach fosters close collaboration with researchers, accelerates idea capture, and bridges hospital-based discoveries with commercialisation pathways.
This case study (2016) highlights the Spinnovator Programme, which helps life science researchers become successful founders. Run by Ascenion, it offers tailored training, mentoring, and funding to turn early-stage technologies into investable spin-offs, strengthening entrepreneurial capacity…
Join our newsletter and get the latest news
We process your data in accordance with GDPR and our Privacy Policy.
